UMPS
Basic information
Region (hg38): 3:124730433-124749273
Links
Phenotypes
GenCC
Source:
- orotic aciduria (Strong), mode of inheritance: AR
- orotic aciduria (Supportive), mode of inheritance: AR
- orotic aciduria (Moderate), mode of inheritance: AR
- orotic aciduria (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Orotic aciduria | AR | Biochemical | Pyrimidine replacement therapy, along with urinary orotic acid monitoring, can be beneficial | Allergy/Immunology/Infectious; Biochemical; Hematologic; Neurologic | 13651334; 14110033; 5347440; 6828110; 6717503; 9042911; 19562503 |
ClinVar
This is a list of variants' phenotypes submitted to
- Oroticaciduria (1 variants)
- Cardiomyopathy (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UMPS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 21 | 28 | ||||
missense | 50 | 54 | ||||
nonsense | 2 | |||||
start loss | 1 | |||||
frameshift | 5 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 97 | 18 | 45 | 160 | ||
Total | 2 | 2 | 155 | 40 | 51 |
Highest pathogenic variant AF is 0.00000657
Variants in UMPS
This is a list of pathogenic ClinVar variants found in the UMPS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-124730444-A-G | Oroticaciduria | Benign (Dec 05, 2021) | ||
3-124730453-A-G | Oroticaciduria | Uncertain significance (Jan 13, 2018) | ||
3-124730473-T-A | Uncertain significance (May 01, 2024) | |||
3-124730473-T-C | Uncertain significance (Sep 16, 2018) | |||
3-124730481-G-C | Hereditary orotic aciduria, type 1 | Uncertain significance (Apr 01, 2024) | ||
3-124730489-A-G | Oroticaciduria • Hereditary orotic aciduria, type 1 | Benign/Likely benign (Sep 26, 2023) | ||
3-124730490-G-C | Uncertain significance (Apr 29, 2024) | |||
3-124730492-T-C | Oroticaciduria • Hereditary orotic aciduria, type 1 | Benign/Likely benign (Jan 18, 2024) | ||
3-124730501-A-G | Hereditary orotic aciduria, type 1 | Likely benign (Apr 16, 2021) | ||
3-124730516-G-A | Hereditary orotic aciduria, type 1 | Likely benign (Jul 06, 2022) | ||
3-124730527-A-T | Hereditary orotic aciduria, type 1 | Uncertain significance (Nov 14, 2020) | ||
3-124730556-A-G | Inborn genetic diseases | Uncertain significance (Oct 01, 2024) | ||
3-124730559-A-G | not specified • Oroticaciduria • Hereditary orotic aciduria, type 1 | Conflicting classifications of pathogenicity (Jan 12, 2024) | ||
3-124730576-C-T | Oroticaciduria | Uncertain significance (Feb 09, 2018) | ||
3-124730577-A-G | Inborn genetic diseases | Likely benign (Mar 26, 2024) | ||
3-124730597-C-A | Hereditary orotic aciduria, type 1 • UMPS-related disorder | Conflicting classifications of pathogenicity (Dec 31, 2019) | ||
3-124735073-A-T | Hereditary orotic aciduria, type 1 | Likely benign (Apr 01, 2022) | ||
3-124735089-A-G | Hereditary orotic aciduria, type 1 | Likely benign (Jun 01, 2021) | ||
3-124735110-C-T | UMPS-related disorder | Likely benign (Aug 17, 2019) | ||
3-124735120-CA-C | Oroticaciduria • Cardiomyopathy | Pathogenic (Mar 06, 2024) | ||
3-124735127-C-T | Inborn genetic diseases | Uncertain significance (Oct 08, 2024) | ||
3-124735146-C-T | Likely benign (Mar 30, 2018) | |||
3-124735158-G-A | Hereditary orotic aciduria, type 1 | Likely benign (Jun 05, 2022) | ||
3-124735166-C-A | Hereditary orotic aciduria, type 1 | Uncertain significance (Aug 14, 2020) | ||
3-124735190-T-C | Hereditary orotic aciduria, type 1 | Uncertain significance (Aug 24, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UMPS | protein_coding | protein_coding | ENST00000232607 | 6 | 14828 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000105 | 0.950 | 125722 | 0 | 26 | 125748 | 0.000103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.14 | 216 | 268 | 0.805 | 0.0000141 | 3107 |
Missense in Polyphen | 53 | 80.839 | 0.65562 | 933 | ||
Synonymous | 0.256 | 99 | 102 | 0.968 | 0.00000550 | 999 |
Loss of Function | 1.78 | 9 | 16.9 | 0.533 | 9.01e-7 | 212 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000316 | 0.000308 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000141 | 0.000141 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Disease
- DISEASE: Orotic aciduria 1 (ORAC1) [MIM:258900]: A disorder of pyrimidine metabolism resulting in megaloblastic anemia and orotic acid crystalluria that is frequently associated with some degree of physical and mental retardation. A minority of cases have additional features, particularly congenital malformations and immune deficiencies. {ECO:0000269|PubMed:9042911}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Fluoropyrimidine Pathway, Pharmacokinetics;Fluoropyrimidine Activity;Pyrimidine metabolism;Metabolism of nucleotides;Pyrimidine biosynthesis;Metabolism;Pentose phosphate cycle;Nucleobase biosynthesis;UMP biosynthesis;superpathway of pyrimidine ribonucleotides <i>de novo</i> biosynthesis;Pyrimidine nucleotides nucleosides metabolism;superpathway of pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.272
Intolerance Scores
- loftool
- 0.579
- rvis_EVS
- -0.42
- rvis_percentile_EVS
- 25.56
Haploinsufficiency Scores
- pHI
- 0.147
- hipred
- N
- hipred_score
- 0.346
- ghis
- 0.637
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.712
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Umps
- Phenotype
Gene ontology
- Biological process
- 'de novo' pyrimidine nucleobase biosynthetic process;UMP biosynthetic process;female pregnancy;lactation;cellular response to drug;'de novo' UMP biosynthetic process;pyrimidine nucleoside biosynthetic process
- Cellular component
- nucleus;cytoplasm;cytosol
- Molecular function
- orotate phosphoribosyltransferase activity;orotidine-5'-phosphate decarboxylase activity